期刊文献+

过表达MiR-494抑制脑胶质瘤细胞U87的增殖

Overexpressed miR-494 inhibits the proliferation of U87 glioma cells
下载PDF
导出
摘要 目的观察微小RNA-494(miR-494)对脑胶质瘤细胞U87增殖能力的影响。方法通过实时荧光定量聚合酶链式反应(qRT-PCR)法检测5例瘤旁组织和14例胶质瘤样本中miR-494的表达水平,并且检测其在6种胶质瘤细胞系中的表达;将100 nmol/L miR-494 mimics瞬时转染至脑胶质瘤U87细胞,qRT-PCR检测miR-494表达情况;采用四唑盐比色法(MTT)检测U87细胞增殖情况;流式细胞术(FCM)检测对U87细胞周期的影响。结果与瘤旁脑组织相比,miR-494在胶质瘤中呈现低表达;U87细胞转染48 h后,miR-494 mimics组miR-494表达为对照组的357倍(P<0.05);与对照组相比,miR-494 mimics转染后抑制了U87细胞的增殖能力(P<0.05);S期细胞显著减少,而G1期细胞则明显增多。结论 miR-494在胶质瘤中低表达,过表达miR-494 mimics有效抑制了U87细胞的增殖,调节细胞周期S期降低G1期增多,提示miR-494有望成为胶质瘤治疗的分子靶点。 Objective The role of miR-494 on the cell proliferation of human U87 glioma cell lines is discussed. Methods Quantitative real-time reverse transcription polymerase chain reaction( qRT-PCR)was applied to detect the expression of miR-494 in 5 human normal brain tissues,14 glioma tissues and 6glioma cell lines; miR-494 was transiently transfected into U87 glioma cells( 100 nmol / L); Mosmann Tetrazolium Test( MTT) assay was used to detect the cell proliferation; the cell cycle was measured by flow cytometry( FCM). Results miR-494 was low expressed in glioma tissues compared with normal samples.The expression of miR-494 was as 357 folds as the control(P 0. 05) after transient transfecting with miR-494 mimics. Decreased proliferation and G1-to-S cell cycle progression were detected in the miR-494 mimics transfected U87 glioma cells( P 0. 05). Conclusion The expression of miR-494 is aberrantly low in glioma tissues. Transient transfection of miR-494 mimics leads to decreased proliferation and G1-to-S cell cycle progression in U87 glioma cells,indicating that miR-494 might be a new molecular target for the treatment for glioma.
出处 《中华神经外科疾病研究杂志》 CAS 2014年第5期408-411,共4页 Chinese Journal of Neurosurgical Disease Research
关键词 微小RNA-494 胶质瘤 细胞增殖 细胞周期 MiR-494 Glioma Cell proliferation Cell cycle
  • 相关文献

参考文献17

  • 1Butowski NA, Sneed PK, Chang SM. Diagnosis and treatment of recurrent high-grade astrocytoma [J]. J Clin Oncol, 2006, 24(8) : 1273 -1280.
  • 2Van Meir EG, Hadjipanayis CG, Norden AD, et al. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma [J]. CA CancerJ Clin, 2010, 60(3) : 166-193.
  • 3Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma [ J ]. N Engl J Med, 2005, 352(10) : 987 - 996.
  • 4Sana J, Hajduch M, Michalek J, et al. MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implications [J]. J Cell Mol Med, 2011, 15(8) : 1636 -1644.
  • 5Gtitte M. MicroRNAs in breast cancer pathogenesis [ J ]. Minerva Ginecol, 2010, 62(6) : 559 -571.
  • 6Liu M, Chen H. The role of microRNAs in colorectal cancer [ J ]. J Genet Genomics, 2010, 37(6) : 347 -358.
  • 7Lee YS, Dutta A. MicroRNAs in cancer [ J]. Annu Rev Pathol, 2009, 4:199-227.
  • 8Griffiths-Jones S, Grocock RJ, van Dongen S, et al. miRBase: microRNA sequences, targets and gene nomenclature [ J ]. Nucleic Acids Res, 2006, 34 ( Database issue) : D140 - 144.
  • 9Yamanaka S, Campbell NR, An F, et al. Coordinated effects of microRNA-494 induce G2/M arrest in human cholangiocarcinoma [ J]. Cell Cycle. 2012. 11 (14), 2729 -2738.
  • 10Ohdaira H, Sekiguchi M, Miyata K, et al. MicroRNA494 suppresses cell proliferation and induces senescence in A549 lung cancer cells[ J]. Cell Prolif, 2012, 45(1): 32-38.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部